PRLB
Proto Labs Inc
96.30$
+3.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 37.5% | 38.2% | 38.1% | 31.9% | 34.8% | 35.1% | 32.5% | 19.8% | 23.3% | 26.0% | 26.2% | 29.8% | |
| 15.1% | 13.2% | 16.6% | 7.1% | 13.7% | 18.6% | 17.1% | 7.1% | 7.1% | 10.8% | 12.0% | 14.1% | |
| 25.8% | 22.4% | 26.1% | 18.2% | 21.3% | 23.8% | 21.7% | 8.3% | 10.0% | 13.3% | 13.9% | 16.3% | |
| 8.4% | 11.7% | 8.3% | 10.3% | 10.5% | 8.5% | 7.8% | 8.8% | 10.0% | 9.7% | 9.3% | 10.4% | |
| 2.2% | 2.7% | 2.2% | 2.2% | 1.6% | 1.5% | 1.5% | 1.4% | 1.7% | 1.8% | 1.7% | 1.8% | |
| 31.9% | 34.8% | 33.7% | 32.2% | 36.8% | 39.1% | 38.0% | 31.0% | 32.1% | – | – | – | |
| 10.1% | 8.0% | 7.0% | 25.1% | 20.8% | 19.1% | 17.3% | 43.1% | 34.2% | 35.5% | 36.9% | 35.0% | |
| 1.4% | 0.9% | 0.6% | 3.4% | 3.2% | 2.6% | 1.9% | 4.1% | 3.9% | 3.3% | 2.9% | 2.4% | |
| 7.6% | 9.2% | 8.3% | 10.9% | 12.5% | 13.0% | 13.4% | 10.8% | 13.0% | 10.0% | 9.9% | 14.0% | |
| 6.5% | 7.3% | 5.7% | 8.2% | 8.5% | 7.1% | 6.8% | 5.9% | 8.9% | 6.4% | 7.2% | 8.5% | |
| 0.0% | – | – | 1.0% | – | 0.5% | 0.5% | 0.4% | 2.4% | 0.2% | 0.2% | 0.2% | |
| 2.7% | 3.8% | 2.7% | 3.1% | 2.8% | 2.5% | 2.5% | 2.7% | 2.2% | 2.0% | 2.1% | 1.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 92.4% | 90.8% | 91.7% | 89.1% | 87.5% | 87.0% | 86.6% | 89.2% | 87.0% | 90.0% | 90.1% | 86.0% | |
| 30.4% | 37.1% | 42.7% | 43.4% | 47.1% | 48.2% | 48.8% | 40.6% | 32.2% | 33.2% | 32.9% | 30.7% | |
| 9.1% | 7.3% | 6.4% | 5.2% | 4.4% | 4.0% | 3.6% | 3.0% | 3.4% | 3.4% | 3.4% | 3.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.